Aggregation-Induced Emission Luminogen-Based Dual-Mode Enzyme-Linked Immunosorbent Assay for Ultrasensitive Detection of Cancer Biomarkers in a Broad Concentration Range
Aggregation-Induced Emission Luminogen-Based Dual-Mode Enzyme-Linked Immunosorbent Assay for Ultrasensitive Detection of Cancer Biomarkers in a Broad Concentration Range
复制标题
基于聚集诱导发射发光原的双模式酶联免疫吸附测定,用于宽浓度范围内癌症生物标志物的超灵敏检测
DOI:
10.1021/acssensors.1c02237
复制
发表时间:
2022
期刊:
影响因子:
8.9
通讯作者:
Tang Beng Zhong
中科院分区:
文献类型:
--
作者:
Shen Jianlei;Situ Bo;Du Xianchao;Wang Zhiming;Hu Rong;Li Baixue;Qin Anjun;Tang Beng Zhong
The enzyme-linked immunosorbent assay (ELISA) is one of the most commonly used methods for measuring antibodies and antigens in biological samples. However, developing new ELISAs with high detection sensitivity and broad detection dynamic ranges without resorting to complicated signal processing and equipment setups remains a challenge. In this work, we report a strategy to simultaneously improve the detection sensitivity and broaden the dynamic range by replacing the chromogenic reagents used in traditional ELISAs with an aggregation-induced emission luminogen (AIEgen). The developed AIE–ELISA could generate complementary absorbance and fluorescence signals with a linear detection range of 1.6–25,000 pg/mL. The application of this dual-mode AIE–ELISA in the detection of the prostate-specific antigen (PSA) realized a limit of detection of 1.3 pg/mL (3.78 × 10–14M) and dynamic range improvement of approximately 2 orders of magnitude compared to a single-mode ELISA, which enabled it to discriminate a minor PSA difference in a patient’s serum. The simpler experimental operation, faster enzyme response speed, and better photostability of AIEgen than the traditional chromogenic reagents used in ELISAs showed that our developed AIE–ELISA holds great potential in the fields of immunoassay, immunohistochemistry, and immunocytochemistry.